2-pyrrolidone has been researched along with vigabatrin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chae, WG; Choi, H; Choi, J; Jahng, Y; Je, SM; Kim, EK; Kim, TH; Kim, YC; Lee, ES; Park, M; Zhao, LX | 1 |
| Hyder, F; Mattson, RH; Petroff, OA; Rothman, DL | 1 |
2 other study(ies) available for 2-pyrrolidone and vigabatrin
| Article | Year |
|---|---|
Design and synthesis of anticonvulsive agents as gamma-vinyl GABA-based potential dual acting prodrugs and their biological activities.
Topics: Animals; Anticonvulsants; Bicuculline; Drug Design; Mice; Pentylenetetrazole; Picrotoxin; Prodrugs; Seizures; Vigabatrin | 2000 |
Localized 1H NMR measurements of 2-pyrrolidinone in human brain in vivo.
Topics: Adult; Anticonvulsants; Body Water; Creatine; Epilepsy, Complex Partial; Female; gamma-Aminobutyric Acid; Glycine; Humans; Hydrogen; Magnetic Resonance Spectroscopy; Male; Middle Aged; Occipital Lobe; Phantoms, Imaging; Pyrrolidinones; Treatment Outcome; Vigabatrin | 1999 |